{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T02:30:45Z","timestamp":1791945045892,"version":"4.3.4"},"reference-count":75,"publisher":"Elsevier BV","issue":"15","license":[{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,8,26]],"date-time":"2020-08-26T00:00:00Z","timestamp":1598400000000},"content-version":"vor","delay-in-days":513,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["jbc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Biological Chemistry"],"published-print":{"date-parts":[[2019,4]]},"DOI":"10.1074\/jbc.ra119.007360","type":"journal-article","created":{"date-parts":[[2019,1,29]],"date-time":"2019-01-29T21:45:38Z","timestamp":1548798338000},"page":"5736-5746","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":37,"title":["HIV-1 anchor inhibitors and membrane fusion inhibitors target distinct but overlapping steps in virus entry"],"prefix":"10.1016","volume":"294","author":[{"given":"Dirk","family":"Eggink","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilja","family":"Bontjer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven W.","family":"de Taeye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johannes P.M.","family":"Langedijk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ben","family":"Berkhout","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rogier W.","family":"Sanders","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1074\/jbc.RA119.007360_bib1","first-page":"132","article-title":"2015 Update of the drug resistance mutations in HIV-1","volume":"23","author":"Wensing","year":"2015","journal-title":"Top. Antivir. Med"},{"key":"10.1074\/jbc.RA119.007360_bib2","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1038\/384184a0","article-title":"CD4-dependent, antibody-sensitive interactions between HIV-1 and its co-receptor CCR-5","volume":"384","author":"Trkola","year":"1996","journal-title":"Nature"},{"key":"10.1074\/jbc.RA119.007360_bib3","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1038\/381667a0","article-title":"HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC-CKR-5","volume":"381","author":"Dragic","year":"1996","journal-title":"Nature"},{"key":"10.1074\/jbc.RA119.007360_bib4","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1038\/nrm1076","article-title":"The structural biology of type I viral membrane fusion","volume":"4","author":"Colman","year":"2003","journal-title":"Nat. Rev. Mol. Cell Biol"},{"key":"10.1074\/jbc.RA119.007360_bib5","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1038\/nature13926","article-title":"HIV: A stamp on the envelope","volume":"514","author":"Sanders","year":"2014","journal-title":"Nature"},{"key":"10.1074\/jbc.RA119.007360_bib6","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1038\/nature13808","article-title":"Structure and immune recognition of trimeric pre-fusion HIV-1 Env","volume":"514","author":"Pancera","year":"2014","journal-title":"Nature"},{"key":"10.1074\/jbc.RA119.007360_bib7","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1038\/nsmb.1456","article-title":"Viral membrane fusion","volume":"15","author":"Harrison","year":"2008","journal-title":"Nat. Struct. Mol. Biol"},{"key":"10.1074\/jbc.RA119.007360_bib8","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1083\/jcb.151.2.413","article-title":"Evidence that the transition of HIV-1 gp41 into a six-helix bundle, not the bundle configuration, induces membrane fusion","volume":"151","author":"Melikyan","year":"2000","journal-title":"J. Cell Biol"},{"key":"10.1074\/jbc.RA119.007360_bib9","doi-asserted-by":"crossref","first-page":"9770","DOI":"10.1073\/pnas.91.21.9770","article-title":"Peptides corresponding to a predictive \u03b1-helical domain of human immunodeficiency virus type 1 gp41 are potent inhibitors of virus infection","volume":"91","author":"Wild","year":"1994","journal-title":"Proc. Natl. Acad. Sci. U.S.A"},{"key":"10.1074\/jbc.RA119.007360_bib10","first-page":"S9","article-title":"Clinical safety and efficacy of enfuvirtide (T-20), a new fusion inhibitor: a review of the presentation at the satellite symposium \u201cNew Hope: advancing care in HIV infection\u201d at the 15th annual Association of Nurses in AIDS Care conference, November 2002","volume":"13","author":"Lalezari","year":"2003","journal-title":"AIDS Read"},{"key":"10.1074\/jbc.RA119.007360_bib11","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1089\/apc.2006.0174","article-title":"TORO: ninety-six-week virologic and immunologic response and safety evaluation of enfuvirtide with an optimized background of antiretrovirals","volume":"21","author":"Reynes","year":"2007","journal-title":"AIDS Patient Care STDS"},{"key":"10.1074\/jbc.RA119.007360_bib12","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.cell.2007.02.042","article-title":"Discovery and optimization of a natural HIV-1 entry inhibitor targeting the gp41 fusion peptide","volume":"129","author":"M\u00fcnch","year":"2007","journal-title":"Cell"},{"key":"10.1074\/jbc.RA119.007360_bib13","doi-asserted-by":"crossref","first-page":"63re63","DOI":"10.1126\/scitranslmed.3001697","article-title":"Short-term monotherapy in HIV-infected patients with a virus entry inhibitor against the gp41 fusion peptide","volume":"2","author":"Forssmann","year":"2010","journal-title":"Sci. Translat. Med"},{"key":"10.1074\/jbc.RA119.007360_bib14","doi-asserted-by":"crossref","first-page":"16199","DOI":"10.1038\/nmicrobiol.2016.199","article-title":"An HIV-1 antibody from an elite neutralizer implicates the fusion peptide as a site of vulnerability","volume":"2","author":"van Gils","year":"2016","journal-title":"Nat. Microbiol"},{"key":"10.1074\/jbc.RA119.007360_bib15","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1126\/science.aae0474","article-title":"Fusion peptide of HIV-1 as a site of vulnerability to neutralizing antibody","volume":"352","author":"Kong","year":"2016","journal-title":"Science"},{"key":"10.1074\/jbc.RA119.007360_bib16","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.immuni.2018.07.003","article-title":"Hitting HIV's harpoon","volume":"49","author":"van Gils","year":"2018","journal-title":"Immunity"},{"key":"10.1074\/jbc.RA119.007360_bib17","doi-asserted-by":"crossref","first-page":"e1007159","DOI":"10.1371\/journal.ppat.1007159","article-title":"Complete functional mapping of infection- and vaccine-elicited antibodies against the fusion peptide of HIV","volume":"14","author":"Dingens","year":"2018","journal-title":"PLoS Pathog"},{"key":"10.1074\/jbc.RA119.007360_bib18","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1097\/QAD.0b013e328348a733","article-title":"Development of resistance to VIR-353 with cross-resistance to the natural HIV-1 entry virus inhibitory peptide (VIRIP)","volume":"25","author":"Gonzalez","year":"2011","journal-title":"AIDS"},{"key":"10.1074\/jbc.RA119.007360_bib19","doi-asserted-by":"crossref","first-page":"10587","DOI":"10.1128\/JVI.01616-16","article-title":"HIV-1 escape from a peptidic anchor inhibitor through stabilization of the envelope glycoprotein spike","volume":"90","author":"Eggink","year":"2016","journal-title":"J. Virol"},{"key":"10.1074\/jbc.RA119.007360_bib20","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1016\/j.cell.2015.11.056","article-title":"Immunogenicity of stabilized HIV-1 envelope trimers with reduced exposure of non-neutralizing epitopes","volume":"163","author":"de Taeye","year":"2015","journal-title":"Cell"},{"key":"10.1074\/jbc.RA119.007360_bib21","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1097\/QAD.0b013e32834a36ea","article-title":"Virus-inhibitory peptide: a natural HIV entry inhibitor in search for a formal target in the viral genome","volume":"25","author":"Qui\u00f1ones-Mateu","year":"2011","journal-title":"AIDS"},{"key":"10.1074\/jbc.RA119.007360_bib22","doi-asserted-by":"crossref","first-page":"26941","DOI":"10.1074\/jbc.M109.004416","article-title":"Detailed mechanistic insights into HIV-1 sensitivity to three generations of fusion inhibitors","volume":"284","author":"Eggink","year":"2009","journal-title":"J. Biol. Chem"},{"key":"10.1074\/jbc.RA119.007360_bib23","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1002\/prot.340080202","article-title":"Amphipathic helix motif: classes and properties","volume":"8","author":"Segrest","year":"1990","journal-title":"Proteins"},{"key":"10.1074\/jbc.RA119.007360_bib24","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/1743-422X-3-36","article-title":"The temperature arrested intermediate of virus-cell fusion is a functional step in HIV infection","volume":"3","author":"Henderson","year":"2006","journal-title":"Virol. J"},{"key":"10.1074\/jbc.RA119.007360_bib25","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1186\/1742-4690-8-99","article-title":"Inhibition of HIV-1 endocytosis allows lipid mixing at the plasma membrane, but not complete fusion","volume":"8","author":"de la Vega","year":"2011","journal-title":"Retrovirology"},{"key":"10.1074\/jbc.RA119.007360_bib26","doi-asserted-by":"crossref","first-page":"28821","DOI":"10.1074\/jbc.M112.375949","article-title":"Multifaceted mechanisms of HIV-1 entry inhibition by human \u03b1-defensin","volume":"287","author":"Demirkhanyan","year":"2012","journal-title":"J. Biol. Chem"},{"key":"10.1074\/jbc.RA119.007360_bib27","doi-asserted-by":"crossref","first-page":"13956","DOI":"10.1128\/JVI.01543-14","article-title":"HIV-1 entry in SupT1-R5, CEM-ss, and primary CD4+ T cells occurs at the plasma membrane and does not require endocytosis","volume":"88","author":"Herold","year":"2014","journal-title":"J. Virol"},{"key":"10.1074\/jbc.RA119.007360_bib28","doi-asserted-by":"crossref","first-page":"3249","DOI":"10.1128\/JVI.80.7.3249-3258.2006","article-title":"Membrane-anchored inhibitory peptides capture human immunodeficiency virus type 1 gp41 conformations that engage the target membrane prior to fusion","volume":"80","author":"Melikyan","year":"2006","journal-title":"J. Virol"},{"key":"10.1074\/jbc.RA119.007360_bib29","doi-asserted-by":"crossref","first-page":"12772","DOI":"10.1073\/pnas.0701478104","article-title":"Design of helical, oligomeric HIV-1 fusion inhibitor peptides with potent activity against enfuvirtide-resistant virus","volume":"104","author":"Dwyer","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U.S.A"},{"key":"10.1074\/jbc.RA119.007360_bib30","doi-asserted-by":"crossref","first-page":"10074","DOI":"10.1128\/JVI.74.21.10074-10080.2000","article-title":"Human immunodeficiency virus type 1 spinoculation enhances infection through virus binding","volume":"74","author":"O'Doherty","year":"2000","journal-title":"J. Virol"},{"key":"10.1074\/jbc.RA119.007360_bib31","doi-asserted-by":"crossref","first-page":"16249","DOI":"10.1073\/pnas.252469399","article-title":"Sensitivity of HIV-1 to entry inhibitors correlates with envelope\/coreceptor affinity, receptor density, and fusion kinetics","volume":"99","author":"Reeves","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U.S.A"},{"key":"10.1074\/jbc.RA119.007360_bib32","doi-asserted-by":"crossref","first-page":"10032","DOI":"10.1128\/JVI.01050-08","article-title":"Sequestering of the prehairpin intermediate of gp41 by peptide N36Mut(e,g) potentiates the human immunodeficiency virus type 1 neutralizing activity of monoclonal antibodies directed against the N-terminal helical repeat of gp41","volume":"82","author":"Gustchina","year":"2008","journal-title":"J. Virol"},{"key":"10.1074\/jbc.RA119.007360_bib33","doi-asserted-by":"crossref","first-page":"11161","DOI":"10.1128\/JVI.79.17.11161-11169.2005","article-title":"Ternary complex formation of human immunodeficiency virus type 1 Env, CD4, and chemokine receptor captured as an intermediate of membrane fusion","volume":"79","author":"Mkrtchyan","year":"2005","journal-title":"J. Virol"},{"key":"10.1074\/jbc.RA119.007360_bib34","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1006\/viro.2001.1237","article-title":"Quantitative measurement of fusion of HIV-1 and SIV with cultured cells using photosensitized labeling","volume":"293","author":"Raviv","year":"2002","journal-title":"Virology"},{"key":"10.1074\/jbc.RA119.007360_bib35","doi-asserted-by":"crossref","first-page":"5829","DOI":"10.1128\/JVI.77.10.5829-5836.2003","article-title":"Human immunodeficiency virus type 1 Env with an intersubunit disulfide bond engages coreceptors but requires bond reduction after engagement to induce fusion","volume":"77","author":"Abrahamyan","year":"2003","journal-title":"J. Virol"},{"key":"10.1074\/jbc.RA119.007360_bib36","doi-asserted-by":"crossref","first-page":"5678","DOI":"10.1128\/JVI.77.10.5678-5684.2003","article-title":"Redox-triggered infection by disulfide-shackled human immunodeficiency virus type 1 pseudovirions","volume":"77","author":"Binley","year":"2003","journal-title":"J. Virol"},{"key":"10.1074\/jbc.RA119.007360_bib37","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1742-4690-1-3","article-title":"Evolution of the HIV-1 envelope glycoproteins with a disulfide bond between gp120 and gp41","volume":"1","author":"Sanders","year":"2004","journal-title":"Retrovirology"},{"key":"10.1074\/jbc.RA119.007360_bib38","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1016\/j.immuni.2015.11.007","article-title":"Affinity maturation of a potent family of HIV antibodies is primarily focused on accommodating or avoiding glycans","volume":"43","author":"Garces","year":"2015","journal-title":"Immunity"},{"key":"10.1074\/jbc.RA119.007360_bib39","doi-asserted-by":"crossref","first-page":"2989","DOI":"10.1128\/JVI.02496-08","article-title":"HR-2 mutations in human immunodeficiency virus type 1 gp41 restore fusion kinetics delayed by HR-1 mutations that cause clinical resistance to enfuvirtide","volume":"83","author":"Ray","year":"2009","journal-title":"J. Virol"},{"key":"10.1074\/jbc.RA119.007360_bib40","doi-asserted-by":"crossref","first-page":"10785","DOI":"10.1128\/JVI.05331-11","article-title":"Resistance of human immunodeficiency virus type 1 to a third-generation fusion inhibitor requires multiple mutations in gp41 and is accompanied by a dramatic loss of gp41 function","volume":"85","author":"Eggink","year":"2011","journal-title":"J. Virol"},{"key":"10.1074\/jbc.RA119.007360_bib41","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1097\/QAD.0b013e3280187558","article-title":"Full fusion competence rescue of the enfuvirtide resistant HIV-1 gp41 genotype (43D) by a prevalent polymorphism (137K)","volume":"21","author":"Tolstrup","year":"2007","journal-title":"AIDS"},{"key":"10.1074\/jbc.RA119.007360_bib42","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1128\/AAC.49.3.1113-1119.2005","article-title":"Emergence and evolution of enfuvirtide resistance following long-term therapy involves heptad repeat 2 mutations within gp41","volume":"49","author":"Xu","year":"2005","journal-title":"Antimicrob. Agents Chemother"},{"key":"10.1074\/jbc.RA119.007360_bib43","doi-asserted-by":"crossref","first-page":"4347","DOI":"10.1128\/JVI.79.7.4347-4356.2005","article-title":"Kinetic factors control efficiencies of cell entry, efficacies of entry inhibitors, and mechanisms of adaptation of human immunodeficiency virus","volume":"79","author":"Platt","year":"2005","journal-title":"J. Virol"},{"key":"10.1074\/jbc.RA119.007360_bib44","doi-asserted-by":"crossref","first-page":"12428","DOI":"10.1128\/JVI.78.22.12428-12437.2004","article-title":"Emergence of a drug-dependent human immunodeficiency virus type 1 variant during therapy with the T20 fusion inhibitor","volume":"78","author":"Baldwin","year":"2004","journal-title":"J. Virol"},{"key":"10.1074\/jbc.RA119.007360_bib45","doi-asserted-by":"crossref","first-page":"1896","DOI":"10.1128\/AAC.46.6.1896-1905.2002","article-title":"Emergence of resistant human immunodeficiency virus type 1 in patients receiving fusion inhibitor (T-20) monotherapy","volume":"46","author":"Wei","year":"2002","journal-title":"Antimicrob. Agents Chemother"},{"key":"10.1074\/jbc.RA119.007360_bib46","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1093\/jac\/dkh330","article-title":"Resistance to enfuvirtide, the first HIV fusion inhibitor","volume":"54","author":"Greenberg","year":"2004","journal-title":"J. Antimicrob. Chemother"},{"key":"10.1074\/jbc.RA119.007360_bib47","doi-asserted-by":"crossref","first-page":"6678","DOI":"10.1128\/JVI.00352-08","article-title":"Selection of T1249-resistant human immunodeficiency virus type 1 variants","volume":"82","author":"Eggink","year":"2008","journal-title":"J. Virol"},{"key":"10.1074\/jbc.RA119.007360_bib48","doi-asserted-by":"crossref","first-page":"12447","DOI":"10.1128\/JVI.79.19.12447-12454.2005","article-title":"Impact of human immunodeficiency virus type 1 gp41 amino acid substitutions selected during enfuvirtide treatment on gp41 binding and antiviral potency of enfuvirtide in vitro","volume":"79","author":"Mink","year":"2005","journal-title":"J. Virol"},{"key":"10.1074\/jbc.RA119.007360_bib49","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1089\/aid.2006.22.375","article-title":"Characterization of envelope glycoprotein gp41 genotype and phenotypic susceptibility to enfuvirtide at baseline and on treatment in the phase III clinical trials TORO-1 and TORO-2","volume":"22","author":"Melby","year":"2006","journal-title":"AIDS Res. Hum. Retroviruses"},{"key":"10.1074\/jbc.RA119.007360_bib50","doi-asserted-by":"crossref","first-page":"7735","DOI":"10.1128\/JVI.02524-07","article-title":"Mechanistic studies of a T20-dependent human immunodeficiency virus type 1 variant","volume":"82","author":"Baldwin","year":"2008","journal-title":"J. Virol"},{"key":"10.1074\/jbc.RA119.007360_bib51","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1006\/viro.2001.0888","article-title":"Evolution of AZT resistance in HIV-1: the 41\u201370 intermediate that is not observed in vivo has a replication defect","volume":"283","author":"Jeeninga","year":"2001","journal-title":"Virology"},{"key":"10.1074\/jbc.RA119.007360_bib52","doi-asserted-by":"crossref","first-page":"e1000360","DOI":"10.1371\/journal.ppat.1000360","article-title":"Soluble CD4 and CD4-mimetic compounds inhibit HIV-1 infection by induction of a short-lived activated state","volume":"5","author":"Haim","year":"2009","journal-title":"PLoS Pathog"},{"key":"10.1074\/jbc.RA119.007360_bib53","doi-asserted-by":"crossref","first-page":"e1002101","DOI":"10.1371\/journal.ppat.1002101","article-title":"Contribution of intrinsic reactivity of the HIV-1 envelope glycoproteins to CD4-independent infection and global inhibitor sensitivity","volume":"7","author":"Haim","year":"2011","journal-title":"PLoS Pathog"},{"key":"10.1074\/jbc.RA119.007360_bib54","doi-asserted-by":"crossref","first-page":"8364","DOI":"10.1128\/JVI.00594-09","article-title":"Transitions to and from the CD4-bound conformation are modulated by a single-residue change in the human immunodeficiency virus type 1 gp120 inner domain","volume":"83","author":"Kassa","year":"2009","journal-title":"J. Virol"},{"key":"10.1074\/jbc.RA119.007360_bib55","doi-asserted-by":"crossref","first-page":"e21339","DOI":"10.1371\/journal.pone.0021339","article-title":"Functional stability of unliganded envelope glycoprotein spikes among isolates of human immunodeficiency virus type 1 (HIV-1)","volume":"6","author":"Agrawal","year":"2011","journal-title":"PloS One"},{"key":"10.1074\/jbc.RA119.007360_bib56","doi-asserted-by":"crossref","first-page":"e1003184","DOI":"10.1371\/journal.ppat.1003184","article-title":"Increased functional stability and homogeneity of viral envelope spikes through directed evolution","volume":"9","author":"Leaman","year":"2013","journal-title":"PLoS Pathog"},{"key":"10.1074\/jbc.RA119.007360_bib57","first-page":"67","article-title":"HIV-1 drug resistance mutations: an updated framework for the second decade of HAART","volume":"10","author":"Shafer","year":"2008","journal-title":"AIDS Rev"},{"key":"10.1074\/jbc.RA119.007360_bib58","series-title":"HIV Sequence compendium 2002","first-page":"43","article-title":"Mutational analyses and natural variablility of the gp41 ectodomain","author":"Sanders","year":"2002"},{"key":"10.1074\/jbc.RA119.007360_bib59","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1073\/pnas.89.1.70","article-title":"A mutation in the human immunodeficiency virus type 1 transmembrane glycoprotein gp41 dominantly interferes with fusion and infectivity","volume":"89","author":"Freed","year":"1992","journal-title":"Proc. Natl. Acad. Sci. U.S.A"},{"key":"10.1074\/jbc.RA119.007360_bib60","doi-asserted-by":"crossref","first-page":"4650","DOI":"10.1073\/pnas.87.12.4650","article-title":"Characterization of the fusion domain of the human immunodeficiency virus type 1 envelope glycoprotein gp41","volume":"87","author":"Freed","year":"1990","journal-title":"Proc. Natl. Acad. Sci. U.S.A"},{"key":"10.1074\/jbc.RA119.007360_bib61","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1006\/viro.1996.0169","article-title":"Mutational analysis of the fusion peptide of the human immunodeficiency virus type 1: identification of critical glycine residues","volume":"218","author":"Delahunty","year":"1996","journal-title":"Virology"},{"key":"10.1074\/jbc.RA119.007360_bib62","series-title":"HIV Sequence Compendium 2008","author":"Leitner","year":"2008"},{"key":"10.1074\/jbc.RA119.007360_bib63","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1128\/jvi.69.2.1344-1348.1995","article-title":"Effects of second-site mutations on dominant interference by a human immunodeficiency virus type 1 envelope glycoprotein mutant","volume":"69","author":"Buchschacher","year":"1995","journal-title":"J. Virol"},{"key":"10.1074\/jbc.RA119.007360_bib64","doi-asserted-by":"crossref","first-page":"11359","DOI":"10.1021\/bi990232e","article-title":"Effect of nonpolar substitutions of the conserved Phe11 in the fusion peptide of HIV-1 gp41 on its function, structure, and organization in membranes","volume":"38","author":"Pritsker","year":"1999","journal-title":"Biochemistry"},{"key":"10.1074\/jbc.RA119.007360_bib65","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1110\/ps.03172703","article-title":"The specificity of cross-reactivity: promiscuous antibody binding involves specific hydrogen bonds rather than nonspecific hydrophobic stickiness","volume":"12","author":"James","year":"2003","journal-title":"Protein Sci"},{"key":"10.1074\/jbc.RA119.007360_bib66","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.jmb.2007.01.077","article-title":"Promiscuous binding of ligands by \u03b2-lactoglobulin involves hydrophobic interactions and plasticity","volume":"368","author":"Konuma","year":"2007","journal-title":"J. Mol. Biol"},{"key":"10.1074\/jbc.RA119.007360_bib67","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/S1359-6446(03)03008-3","article-title":"Predicting undesirable drug interactions with promiscuous proteins in silico","volume":"9","author":"Ekins","year":"2004","journal-title":"Drug Discov. Today"},{"key":"10.1074\/jbc.RA119.007360_bib68","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/S0969-2126(98)00072-0","article-title":"A promiscuous binding surface: crystal structure of the IIA domain of the glucose-specific permease from Mycoplasma capricolum","volume":"6","author":"Huang","year":"1998","journal-title":"Structure"},{"key":"10.1074\/jbc.RA119.007360_bib69","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1126\/science.278.5346.2085","article-title":"Immune versus natural selection: antibody aldolases with enzymic rates but broader scope","volume":"278","author":"Barbas","year":"1997","journal-title":"Science"},{"key":"10.1074\/jbc.RA119.007360_bib70","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/0161-5890(94)90001-9","article-title":"Anatomy of the antibody molecule","volume":"31","author":"Padlan","year":"1994","journal-title":"Mol. Immunol"},{"key":"10.1074\/jbc.RA119.007360_bib71","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.jim.2013.11.022","article-title":"Optimization and validation of the TZM-bl assay for standardized assessments of neutralizing antibodies against HIV-1","volume":"409","author":"Sarzotti-Kelsoe","year":"2014","journal-title":"J. Immunol. Methods"},{"key":"10.1074\/jbc.RA119.007360_bib72","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1007\/978-1-59745-170-3_26","article-title":"Measuring HIV neutralization in a luciferase reporter gene assay","volume":"485","author":"Montefiori","year":"2009","journal-title":"Methods Mol. Biol"},{"key":"10.1074\/jbc.RA119.007360_bib73","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/0042-6822(91)90537-L","article-title":"Changes in growth properties on passage in tissue culture of viruses derived from infectious molecular clones of HIV-1LAI, HIV-1MAL, and HIV-1ELI","volume":"185","author":"Peden","year":"1991","journal-title":"Virology"},{"key":"10.1074\/jbc.RA119.007360_bib74","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1089\/0889222041524544","article-title":"Evolutionary repair of HIV type 1 gp41 with a kink in the N-terminal helix leads to restoration of the six-helix bundle structure","volume":"20","author":"Sanders","year":"2004","journal-title":"AIDS Res. Hum. Retroviruses"},{"key":"10.1074\/jbc.RA119.007360_bib75","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1128\/JVI.73.1.81-91.1999","article-title":"A hairpin structure in the R region of the human immunodeficiency virus type 1 RNA genome is instrumental in polyadenylation site selection","volume":"73","author":"Das","year":"1999","journal-title":"J. Virol"}],"updated-by":[{"DOI":"10.1016\/j.jbc.2022.101811","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000}}],"container-title":["Journal of Biological Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021925820366424?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021925820366424?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1074\/jbc.RA119.007360","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,4]],"date-time":"2022-01-04T08:08:01Z","timestamp":1641283681000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021925820366424"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4]]},"references-count":75,"journal-issue":{"issue":"15","published-print":{"date-parts":[[2019,4]]}},"alternative-id":["S0021925820366424"],"URL":"https:\/\/doi.org\/10.1074\/jbc.ra119.007360","relation":{},"ISSN":["0021-9258"],"issn-type":[{"value":"0021-9258","type":"print"}],"subject":[],"published":{"date-parts":[[2019,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"HIV-1 anchor inhibitors and membrane fusion inhibitors target distinct but overlapping steps in virus entry","name":"articletitle","label":"Article Title"},{"value":"Journal of Biological Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1074\/jbc.RA119.007360","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Eggink et al.","name":"copyright","label":"Copyright"}]}}